FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2783330086> ?p ?o ?g. }

• W2783330086 abstract "Summary Ample evidences demonstrate that cytochrome P450 epoxygenase‐derived epoxyeicosatrienoic acids ( EET s) exert diverse biological activities, which include potent vasodilatory, anti‐inflammatory, and cardiovascular protective effects. In this study, we investigated the effects of endothelium‐specific CYP 2J2 overexpression on age‐related insulin resistance and metabolic dysfunction. Endothelium‐specific targeting of the human CYP epoxygenase, CYP 2J2, transgenic mice (Tie2‐ CYP 2J2‐Tr mice) was utilized. The effects of endothelium‐specific CYP 2J2 overexpression on aging‐associated obesity, inflammation, and peripheral insulin resistance were evaluated by assessing metabolic parameters in young (3 months old) and aged (16 months old) adult male Tie2‐ CYP 2J2‐Tr mice. Decreased insulin sensitivity and attenuated insulin signaling in aged skeletal muscle, adipose tissue, and liver were observed in aged adult male mice, and moreover, these effects were partly inhibited in 16‐month‐old CYP 2J2‐Tr mice. In addition, CYP 2J2 overexpression‐mediated insulin sensitization in aged mice was associated with the amelioration of inflammatory state. Notably, the aging‐associated increases in fat mass and adipocyte size were only observed in 16‐month‐old wild‐type mice, and CYP 2J2 overexpression markedly prevented the increase in fat mass and adipocyte size in aged Tie2‐ CYP 2J2‐Tr mice, which was associated with increased energy expenditure and decreased lipogenic genes expression. Furthermore, these antiaging phenotypes of Tie2‐ CYP 2J2‐Tr mice were also associated with increased muscle blood flow, enhanced active‐phase locomotor activity, and improved mitochondrial dysfunction in skeletal muscle. Collectively, our findings indicated that endothelium‐specific CYP 2J2 overexpression alleviated age‐related insulin resistance and metabolic dysfunction, which highlighted CYP epoxygenase‐ EET system as a potential target for combating aging‐related metabolic disorders." @default.
• W2783330086 created "2018-01-26" @default.
• W2783330086 creator A5006343463 @default.
• W2783330086 creator A5008863776 @default.
• W2783330086 creator A5014137444 @default.
• W2783330086 creator A5038333457 @default.
• W2783330086 creator A5065117547 @default.
• W2783330086 creator A5080998212 @default.
• W2783330086 creator A5082713850 @default.
• W2783330086 creator A5083010844 @default.
• W2783330086 creator A5090376798 @default.
• W2783330086 date "2018-01-10" @default.
• W2783330086 modified "2023-09-29" @default.
• W2783330086 title "Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance" @default.
• W2783330086 cites W1496765093 @default.
• W2783330086 cites W1587875569 @default.
• W2783330086 cites W1701180504 @default.
• W2783330086 cites W1963705367 @default.
• W2783330086 cites W1971524892 @default.
• W2783330086 cites W1973842058 @default.
• W2783330086 cites W1984222509 @default.
• W2783330086 cites W1990202372 @default.
• W2783330086 cites W1992519340 @default.
• W2783330086 cites W2002937742 @default.
• W2783330086 cites W2005812052 @default.
• W2783330086 cites W2011609324 @default.
• W2783330086 cites W2012037560 @default.
• W2783330086 cites W2033368542 @default.
• W2783330086 cites W2039765544 @default.
• W2783330086 cites W2040043082 @default.
• W2783330086 cites W2043523148 @default.
• W2783330086 cites W2053686067 @default.
• W2783330086 cites W2063405868 @default.
• W2783330086 cites W2078807483 @default.
• W2783330086 cites W2092875386 @default.
• W2783330086 cites W2098494341 @default.
• W2783330086 cites W2101242243 @default.
• W2783330086 cites W2101758812 @default.
• W2783330086 cites W2105199683 @default.
• W2783330086 cites W2107146209 @default.
• W2783330086 cites W2113370950 @default.
• W2783330086 cites W2127722031 @default.
• W2783330086 cites W2131250713 @default.
• W2783330086 cites W2146608915 @default.
• W2783330086 cites W2148713009 @default.
• W2783330086 cites W2148798898 @default.
• W2783330086 cites W2149675148 @default.
• W2783330086 cites W2163160776 @default.
• W2783330086 cites W2168182860 @default.
• W2783330086 cites W2261112793 @default.
• W2783330086 cites W2276466435 @default.
• W2783330086 cites W2317788901 @default.
• W2783330086 cites W2340669800 @default.
• W2783330086 cites W2469491796 @default.
• W2783330086 cites W2512703206 @default.
• W2783330086 cites W2563017338 @default.
• W2783330086 cites W2564206164 @default.
• W2783330086 cites W98817010 @default.
• W2783330086 doi "https://doi.org/10.1111/acel.12718" @default.
• W2783330086 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5847864" @default.
• W2783330086 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/29318723" @default.
• W2783330086 hasPublicationYear "2018" @default.
• W2783330086 type Work @default.
• W2783330086 sameAs 2783330086 @default.
• W2783330086 citedByCount "14" @default.
• W2783330086 countsByYear W27833300862018 @default.
• W2783330086 countsByYear W27833300862019 @default.
• W2783330086 countsByYear W27833300862020 @default.
• W2783330086 countsByYear W27833300862021 @default.
• W2783330086 countsByYear W27833300862022 @default.
• W2783330086 countsByYear W27833300862023 @default.
• W2783330086 crossrefType "journal-article" @default.
• W2783330086 hasAuthorship W2783330086A5006343463 @default.
• W2783330086 hasAuthorship W2783330086A5008863776 @default.
• W2783330086 hasAuthorship W2783330086A5014137444 @default.
• W2783330086 hasAuthorship W2783330086A5038333457 @default.
• W2783330086 hasAuthorship W2783330086A5065117547 @default.
• W2783330086 hasAuthorship W2783330086A5080998212 @default.
• W2783330086 hasAuthorship W2783330086A5082713850 @default.
• W2783330086 hasAuthorship W2783330086A5083010844 @default.
• W2783330086 hasAuthorship W2783330086A5090376798 @default.
• W2783330086 hasBestOaLocation W27833300861 @default.
• W2783330086 hasConcept C126322002 @default.
• W2783330086 hasConcept C134018914 @default.
• W2783330086 hasConcept C171089720 @default.
• W2783330086 hasConcept C185592680 @default.
• W2783330086 hasConcept C2776914184 @default.
• W2783330086 hasConcept C2776992346 @default.
• W2783330086 hasConcept C2777391703 @default.
• W2783330086 hasConcept C2779306644 @default.
• W2783330086 hasConcept C2779396086 @default.
• W2783330086 hasConcept C2779959927 @default.
• W2783330086 hasConcept C526171541 @default.
• W2783330086 hasConcept C62231903 @default.
• W2783330086 hasConcept C71924100 @default.
• W2783330086 hasConcept C86803240 @default.
• W2783330086 hasConceptScore W2783330086C126322002 @default.
• W2783330086 hasConceptScore W2783330086C134018914 @default.
• W2783330086 hasConceptScore W2783330086C171089720 @default.
• W2783330086 hasConceptScore W2783330086C185592680 @default.

• next